{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:29:28Z","timestamp":1747168168995,"version":"3.40.5"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neurobiolaging.2018.12.021","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T16:54:53Z","timestamp":1551459293000},"page":"166-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Whole exome should be preferred over Sanger sequencing in suspected mitochondrial myopathy"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-7305","authenticated-orcid":false,"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.12.021_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-014-0421-1","article-title":"Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy","volume":"16","author":"Ajroud-Driss","year":"2015","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2018.12.021_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/146608202760839008","article-title":"Mitochondriopathy as a differential diagnosis of amyotrophic lateral sclerosis","volume":"3","author":"Finsterer","year":"2002","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.neurobiolaging.2018.12.021_bib3","doi-asserted-by":"crossref","first-page":"177.e9","DOI":"10.1016\/j.neurobiolaging.2016.12.008","article-title":"Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients","volume":"51","author":"Perrone","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.12.021_bib4","doi-asserted-by":"crossref","first-page":"193.e7","DOI":"10.1016\/j.neurobiolaging.2016.12.027","article-title":"Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease","volume":"53","author":"Rubino","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.12.021_bib5","doi-asserted-by":"crossref","first-page":"181.e1","DOI":"10.1016\/j.neurobiolaging.2018.02.007","article-title":"Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy","volume":"66","author":"Rubino","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.12.021_bib6","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1007\/s12035-016-0056-3","article-title":"Identification of CHCHD10 mutation in Chinese patients with Alzheimer disease","volume":"54","author":"Xiao","year":"2017","journal-title":"Mol. Neurobiol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019300648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019300648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T16:16:06Z","timestamp":1565712966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019300648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":6,"alternative-id":["S0197458019300648"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.021","relation":{},"ISSN":["0197-4580"],"issn-type":[{"type":"print","value":"0197-4580"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole exome should be preferred over Sanger sequencing in suspected mitochondrial myopathy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.02.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}